Sprangers M, Feldhahn N, Liedtke S, Jumaa H, Siebert R, Müschen M
Laboratory for Molecular Stem Cell Biology, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany.
Oncogene. 2006 Aug 24;25(37):5180-6. doi: 10.1038/sj.onc.1209520. Epub 2006 Apr 24.
Perpetual V(D)J recombinase activity involving multiple DNA double-strand break events in B-cell lineage leukemia and lymphoma cells may introduce secondary genetic aberrations leading towards malignant progression. Here, we investigated defective negative feedback signaling through the (pre-) B-cell receptor as a possible reason for deregulated V(D)J recombinase activity in B-cell malignancy. On studying 28 cases of pre-B-lymphoblastic leukemia and 27 B-cell lymphomas, expression of the (pre-) B-cell receptor-related linker molecule SLP65 (SH2 domain-containing lymphocyte protein of 65 kDa) was found to be defective in seven and five cases, respectively. SLP65 deficiency correlates with RAG1/2 expression and unremitting V(H) gene rearrangement activity. Reconstitution of SLP65 expression in SLP65-deficient leukemia and lymphoma cells results in downregulation of RAG1/2 expression and prevents both de novo V(H)-DJ(H) rearrangements and secondary V(H) replacement. We conclude that iterative V(H) gene rearrangement represents a frequent feature in B-lymphoid malignancy, which can be attributed to SLP65 deficiency in many cases.
在B细胞系白血病和淋巴瘤细胞中,涉及多个DNA双链断裂事件的持续V(D)J重组酶活性可能会引发继发性基因畸变,导致恶性进展。在此,我们研究了通过(前)B细胞受体的缺陷性负反馈信号传导,作为B细胞恶性肿瘤中V(D)J重组酶活性失调的一个可能原因。在研究28例前B淋巴细胞白血病和27例B细胞淋巴瘤时,发现(前)B细胞受体相关接头分子SLP65(含SH2结构域的65 kDa淋巴细胞蛋白)的表达分别在7例和5例中存在缺陷。SLP65缺陷与RAG1/2表达及持续的V(H)基因重排活性相关。在SLP65缺陷的白血病和淋巴瘤细胞中重建SLP65表达会导致RAG1/2表达下调,并阻止从头V(H)-DJ(H)重排和继发性V(H)置换。我们得出结论,迭代V(H)基因重排是B淋巴细胞恶性肿瘤的一个常见特征,在许多情况下可归因于SLP65缺陷。